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doi:10.1016/j.ejvs.2011.08.005Abstract We present a case of an infected stent graft in the superficial femoral artery (SFA).
A 67-year-old woman underwent excision of an infected Viabahn stent graft. At exploration
there was no apparent artery around the majority of the stent graft, suggesting that the
SFA had been autolysed.
Infected stents and stent grafts are rare in the SFA position. The risk of infection is likely
minimised with standard treatments including drainage of infection prior to stent graft place-
ment and periprocedural antibiotic administration. Successful management will, in most
cases, require excision of the stent graft and adjunctive arterial reconstruction, as necessary.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Infections are unusual in peripheral arteries treated with
endovascular techniques. The use of stents and stent grafts
for segment superficial femoral artery (SFA) disease might
be associated with a higher infection rate, but there are
few published descriptions of such problems. We present
a case of an infected stent graft in the SFA.t the 39th Annual Symposium
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A 67-year-old diabetic woman presented with a 2.5-month
history of foot pain and two ischaemic foot ulcers, one
measuring 2.2  2.4 cm over the lateral aspect of the 5th
metatarsophalangeal joint, the other measuring
1.1  2.0 cm over the posterior heel. There was no fever,
local erythema, drainage, odour or other suggestion of
infection. The patient underwent endovascular treatment
for atherosclerotic disease including placement of
a 6 mm  15 cm Viabahn stent graft (W.L. Gore, Flagstaff,
AZ, USA) in the distal SFA and atherectomy of the popliteal
artery and anterior tibial artery (Silverhawk, Fox Hollow/
ev3, Plymouth, MN, USA) on hospital day 4 using contra-
lateral femoral access (Fig. 1). The lesions were initially
crossed with hydrophilic wires and no ‘crossing device’ wasd by Elsevier Ltd. All rights reserved.
Figure 1 A) and B) pre-intervention angiogram revealing diffuse disease of the superficial femoral artery including several areas
of very high grade stenosis and high grade disease in the distal popliteal and proximal anterior tibial artery (single runoff artery),
respectfully. C) and D) similar views to A) and B) after Viabahn placement in the superficial femoral artery and atherectomy of the
popliteal and anterior tibial arteries respectfully.
700 J.R. Schneider et al.employed. The entire procedure took 90 min to complete.
Piperacillin/tazobactam was administered empirically
beginning at admission 4 days before the procedure, but
gastrointestinal toxicity prompted a switch to clindamycin
and ciprofloxacin after 2 days. Corticosteroids were given
for iodine allergy. Methicillin-resistant Staphylococcus
aureus (MRSA) grew from a blood culture obtained because
of fever 1 day after stent graft placement and vancomycin
(to which the MRSA was sensitive) was administered for 17
days. Despite a technically successful result with normal
triphasic Doppler waveform at the distal anterior tibial
artery, foot perfusion was still suboptimal. The anterior
tibial was the single patent runoff artery and no named
artery crossed the ankle or appeared on the foot so thatdirect bypass would not have been expected to enhance
perfusion further. The patient suffered progression of
forefoot gangrene, repeat angiography confirmed patency
of the treated arteries with no apparent options to enhance
foot flow and the patient required below-knee amputation.
She was maintained on trimethoprim/sulfamethoxazole
(to which the MRSA was sensitive) for 2 months after
discharge. Her amputation healed, but she complained of
persistent severe pain in the mid-thigh beginning soon after
initial treatment. She exhibited no vital sign abnormalities or
worsened hyperglycaemia. Ultrasound imaging 5 months
after stent graft placement revealed an occluded stent graft,
butnofluid collection in the thigh.Afluidcollectionappeared
in the skin and subcutaneous tissue of the medial thigh 6
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culture-negative fluid and no apparent sinus to any deeper
fluid collection. Magnetic resonance imaging (MRI) at this
time was limited due to patient refusal of intravenous
contrast administration, but suggested only oedema in the
posteromedial thigh.However, repeatduplex imaging12days
later (6.5 months after initial procedure) revealed a large
fluid collection adjacent to the SFA and stent.
Exploration proceeded using an anteromedial approach.
A large cavity filled with murky fluid was encountered. The
Viabahn stent graft was observed at the base of the fluid
collection (Fig. 2A) with no apparent SFA around the
exposed mid-portion of the stent graft, suggesting autolysis
of the SFA. Frank pus drained after the distal end of the
graft was extracted (Fig. 2B), but there was no haemor-
rhage. Wound cultures were positive for MRSA. The patient
was treated with vancomycin and the wound healed over 6
weeks with local care.Figure 2 A) Approach from anteromedial right thigh, longi-
tudinal incision, patient’s head to the right of the picture and
knee to the left of the picture. The Viabahn stent graft is
visible (arrow) in the cavity in the depth of the wound and
there is no apparent artery covering the stent graft, implying
likely autolysis of the artery. B) Less magnified, but similar
perspective as Fig. 2A. The Viabahn stent graft has been
removed and is lying on the skin at the very bottom of the
picture. Frank pus is noted in the bed of the stent graft
(arrow).Comment
Infected metal stents are rare, with risk estimated to be of
the order of 1 in 10 000 by Myles et al.,1 almost certainly an
underestimate as it is based on published reports of infec-
tion versus annual stent placement volume. Infected aortic
endografts are unusual, but have been reported.2,3
However, few reports describe stent-associated infections
in the SFA.4e8
Endovascular treatment has in the past yielded signifi-
cantly poorer outcomes than autologous vein bypass for
long-segment (Transatlantic Inter-Society Consensus for
Management of PAD: TASC C and TASC D) SFA disease.9 Many
investigators have examined the possible benefit of using
stent grafts in such cases.10e16 Expanded polytetrafluoro-
ethylene (ePTFE)-covered Hemobahn (also W.L. Gore and
the predecessor to the Viabahn) and Viabahn stent grafts or
polyester-covered stent grafts might be more susceptible to
infection than would an uncovered stent. However, despite
frequent use of the Viabahn, particularly in the SFA,17 our
literature search identified just two previous published
reports of infected stent grafts (both Hemobahns) in the
SFA5,6 and these two reports likely describe the same
patient, as they came from two institutions on the same
campus and both included spinal discitis. We were unable
to identify any reports of infected Viabahn grafts in any
location. Thus, infections of Viabahn stent graft must be
extremely unusual.
Patients occasionally report pain after placement of
stents and stent grafts, even in the absence of infection15,18
and we considered this explanation for the pain. However,
we were concerned about infection throughout our
patient’s postoperative course as she complained of pain in
the thigh (remote from the contralateral arterial access
and from the amputation site). We presume that the foot
was the source of the MRSA bacteraemia, likely seeding the
stent graft in our patient. Infection has been observed after
endovascular procedures even in the absence of any
implanted device, although aggressive debridement and
drainage of any infection before any arterial procedure
reduces this risk.19,20 Corticosteroid administration also
likely increased our patient’s susceptibility to infection.
The indolent course is remarkable as we presume stent
graft infection virtually immediately after placement. We
suspect that the progression was due to obliteration of the
named vessels on the foot and initial tissue loss outside of
the anterior tibial angiosome so that even though there was
evidence for satisfactory improvement in the single runoff
vessel, the blood flow was likely still suboptimal at the site
of the tissue loss.
The autolysis of the SFA was striking. The presence of
the foreign body may predispose to continued suppuration
and arterial destruction,21,22 although arterial destruction
is often observed in the presence of arterial infection even
without the presence of foreign material.23,24 We were
fortunate that extraction of the stent graft did not result in
haemorrhage. The possibility that an infected uncovered
stent might have permitted development of a mycotic
pseudo-aneurysm, whereas the covered stent may have
prevented pseudo-aneurysm before the artery thrombosed,
is intriguing.
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reinforces general experience with bacterial arteritis in the
presence of prosthetic material, that is, non-operative
therapy is typically associated with serious morbidity and
mortality.25e28 Removal of the infected artery and stent,
antibiotic therapy and drainage are generally recommended
with arterial reconstruction, when appropriate,25,29
although there have been reports of resolution without
stent excision.1,25,30,31 However, themorbidity andmortality
of operative therapy are substantial,1,8,32 due partly to the
fact that most reported stent infections are intra-abdominal
or intrathoracic making definitive excision and drainage
a formidable task. Our patient had relief from pain and rapid
healing of her wound after removal of the infected stent
graft. No arterial reconstruction was required, as she had
already undergone below-knee amputation.Conflict of Interest/Funding
None declared.References
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